Gesves, Belgium

Fabien Ectors

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Cryoport Belgium S.a.. Active years: 2025.

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Fabien Ectors: Innovator in Cryopreservation Technology

Introduction

Fabien Ectors is a notable inventor based in Gesves, Belgium. He has made significant contributions to the field of cryopreservation, particularly through his innovative patent that addresses the preservation of biological materials. His work is essential for advancements in various scientific and medical applications.

Latest Patents

Fabien Ectors holds 1 patent for his invention titled "Compositions for cryopreservation of a biological material." This patent discloses a liquid composition that includes a polar aprotic solvent, a monohydric or polyhydric alcohol, an unbranched polysaccharide, a branched polysaccharide, and polyvinyl alcohol. The composition is designed for the cryopreservation of biological materials, providing methods for preserving such materials effectively.

Career Highlights

Fabien Ectors is currently associated with Cryoport Belgium S.A., where he continues to develop and refine technologies related to cryopreservation. His expertise in this area has positioned him as a key player in the field, contributing to advancements that benefit both research and clinical practices.

Collaborations

Fabien collaborates with talented professionals in his field, including Luc Grobet and Delphine Connan. These partnerships enhance the innovative capacity of his work and contribute to the success of their projects.

Conclusion

Fabien Ectors is a pioneering inventor whose work in cryopreservation is making a significant impact in the scientific community. His contributions are vital for the future of biological material preservation.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…